Yanfei Chen1, Cheng Ding1, Ling Yu1, Wanru Guo1, Xuewen Feng1, Liang Yu1, Junwei Su1, Ting Xu1, Cheng Ren1, Ding Shi1, Wenrui Wu1, Ping Yi1, Jun Liu1, Jingjing Tao1, Guanjing Lang1, Yongtao Li1, Min Xu1, Jifang Sheng1, Lanjuan Li2, Kaijin Xu3. 1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou City, 310003, China. 2. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou City, 310003, China. ljli@zju.edu.cn. 3. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou City, 310003, China. zdyxyxkj@zju.edu.cn.
Abstract
BACKGROUND: Knowledge about the 1-year outcome of COVID-19 is limited. The aim of this study was to follow-up and evaluate lung abnormalities on serial computed tomography (CT) scans in patients with COVID-19 after hospital discharge. METHODS: A prospective cohort study of patients with COVID-19 from the First Affiliated Hospital, Zhejiang University School of Medicine was conducted, with assessments of chest CT during hospitalization and at 2 weeks, 1 month, 3 months, 6 months, and 1 year after hospital discharge. Risk factors of residual CT opacities and the influence of residual CT abnormalities on pulmonary functions at 1 year were also evaluated. RESULTS: A total of 41 patients were followed in this study. Gradual recovery after hospital discharge was confirmed by the serial CT scores. Around 47% of the patients showed residual aberration on pulmonary CT with a median CT score of 0 (interquartile range (IQR) of 0-2) at 1 year after discharge, with ground-glass opacity (GGO) with reticular pattern as the major radiologic pattern. Patients with residual radiological abnormalities were older (p = 0.01), with higher rate in current smokers (p = 0.04), higher rate in hypertensives (p = 0.05), lower SaO2 (p = 0.004), and higher prevalence of secondary bacterial infections during acute phase (p = 0.02). Multiple logistic regression analyses indicated that age was a risk factor associated with residual radiological abnormalities (OR 1.08, 95% CI 1.01-1.15, p = 0.02). Pulmonary functions of total lung capacity (p = 0.008) and residual volume (p < 0.001) were reduced in patients with residual CT abnormalities and were negatively correlated with CT scores. CONCLUSION: During 1-year follow-up after discharge, COVID-19 survivors showed continuous improvement on chest CT. However, residual lesions could still be observed and correlated with lung volume parameters. The risk of developing residual CT opacities increases with age.
BACKGROUND: Knowledge about the 1-year outcome of COVID-19 is limited. The aim of this study was to follow-up and evaluate lung abnormalities on serial computed tomography (CT) scans in patients with COVID-19 after hospital discharge. METHODS: A prospective cohort study of patients with COVID-19 from the First Affiliated Hospital, Zhejiang University School of Medicine was conducted, with assessments of chest CT during hospitalization and at 2 weeks, 1 month, 3 months, 6 months, and 1 year after hospital discharge. Risk factors of residual CT opacities and the influence of residual CT abnormalities on pulmonary functions at 1 year were also evaluated. RESULTS: A total of 41 patients were followed in this study. Gradual recovery after hospital discharge was confirmed by the serial CT scores. Around 47% of the patients showed residual aberration on pulmonary CT with a median CT score of 0 (interquartile range (IQR) of 0-2) at 1 year after discharge, with ground-glass opacity (GGO) with reticular pattern as the major radiologic pattern. Patients with residual radiological abnormalities were older (p = 0.01), with higher rate in current smokers (p = 0.04), higher rate in hypertensives (p = 0.05), lower SaO2 (p = 0.004), and higher prevalence of secondary bacterial infections during acute phase (p = 0.02). Multiple logistic regression analyses indicated that age was a risk factor associated with residual radiological abnormalities (OR 1.08, 95% CI 1.01-1.15, p = 0.02). Pulmonary functions of total lung capacity (p = 0.008) and residual volume (p < 0.001) were reduced in patients with residual CT abnormalities and were negatively correlated with CT scores. CONCLUSION: During 1-year follow-up after discharge, COVID-19 survivors showed continuous improvement on chest CT. However, residual lesions could still be observed and correlated with lung volume parameters. The risk of developing residual CT opacities increases with age.
Authors: D S Hui; G M Joynt; K T Wong; C D Gomersall; T S Li; G Antonio; F W Ko; M C Chan; D P Chan; M W Tong; T H Rainer; A T Ahuja; C S Cockram; J J Y Sung Journal: Thorax Date: 2005-05 Impact factor: 9.139
Authors: Gaik C Ooi; Pek L Khong; Nestor L Müller; Wai C Yiu; Lin J Zhou; James C M Ho; Bing Lam; Savvas Nicolaou; Kenneth W T Tsang Journal: Radiology Date: 2004-03 Impact factor: 11.105
Authors: Christopher C Huntley; Ketan Patel; Shahnoor-E-Salam Bil Bushra; Farah Mobeen; Michael N Armitage; Anita Pye; Chloe B Knight; Alyaa Mostafa; Marie Kershaw; Aishah Z Mughal; Emily McKemey; Alice M Turner; P Sherwood Burge; Gareth I Walters Journal: ERJ Open Res Date: 2022-05-30
Authors: Gabriel Hanna; Sara Bankler; Anna Schandl; Mari Roël; Anders Hedman; Mikael Andersson Franko; Patrik Lyngå; Anne Geborek; Eva Joelsson-Alm; Mårten Söderberg; Pernilla Darlington Journal: Clin Respir J Date: 2021-10-27 Impact factor: 1.761
Authors: Marco Marando; Tanja Fusi-Schmidhauser; Adriana Tamburello; Lorenzo Grazioli Gauthier; Elia Rigamonti; Gianluca Argentieri; Carla Puligheddu; Alberto Pagnamenta; Antonio Valenti; Marco Pons; Pietro Gianella Journal: NPJ Prim Care Respir Med Date: 2022-03-03 Impact factor: 2.871
Authors: Paola Faverio; Fabrizio Luppi; Paola Rebora; Gabriele D'Andrea; Anna Stainer; Sara Busnelli; Martina Catalano; Giuseppe Modafferi; Giovanni Franco; Anna Monzani; Stefania Galimberti; Paolo Scarpazza; Elisa Oggionni; Monia Betti; Tiberio Oggionni; Federica De Giacomi; Francesco Bini; Bruno Dino Bodini; Mara Parati; Luca Bilucaglia; Paolo Ceruti; Denise Modina; Sergio Harari; Antonella Caminati; Marcello Intotero; Pietro Sergio; Giuseppe Monzillo; Giovanni Leati; Andrea Borghesi; Maurizio Zompatori; Rocco Corso; Maria Grazia Valsecchi; Giacomo Bellani; Giuseppe Foti; Alberto Pesci Journal: Respir Res Date: 2022-03-21